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Background: In an earlier study, we identiﬁed an association between hair relaxer-induced alopecia and
decreased zinc levels. This study hopes to identify if age at ﬁrst exposure to hair relaxer plays a role in the
development of alopecia in the small percentage of women of African descent who use hair-relaxing
products for hair-straightening purposes and develop lingering, nonresolving alopecia.
Methods: Two categories of subjects were recruited for the study. These groupsdGroup A and Group
Bdcommenced use of hair relaxer in the second and third or fourth decade of life, respectively. Group C
which served as the control group consisted of women who had used relaxer but did not manifest
alopecia. Renal and hepatic indices as well as micronutrient levels were estimated in serum samples
taken from these subjects. Data obtained were subjected to statistical analysis using Student t test,
analysis of variance, and Pearson correlation coefﬁcient.
Results: Of all the micronutrients, only zinc level was signiﬁcantly decreased in the two categories of
alopecia subjects compared with controls, and when the zinc levels of the two groups were compared,
they were not signiﬁcantly different. Age in association with an alteration in serum zinc status seemed to
have played an independent or combined role as an etiologic factor in hair relaxer-induced alopecia in
Group B subjects, as a positive correlation (r ¼ 0.631; p ¼ 0.012) was observed between age and duration
of alopecia; alopecia also commenced much earlier in the course of hair relaxer application in Group B
compared with Group A.
Conclusion: This is probably an indication that early exposure may confer some forms of protection even
in zinc-deﬁcient individuals. Moreover, an assessment of serum zinc level in users of hair relaxer may be
encouraged even before initial contact with this agent, such that women at risk could be advised to take
zinc supplements.
Copyright  2011, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
The discovery in the 19th century of alkaline hair relaxers by
Garrett Augustus Morgan paved the way for the use of this agent to
alter the basic structure of the hair shaft. A hair relaxer is a cream
applied to make hair less curly, and its consistent periodic usage
causes the hair to maintain a noncurly appearance. The active
ingredient of many relaxers is a strong alkali, although some
brands contain ammonium thioglycolate. Misuse or excessive
usage has been reported to cause hair breakage or alopecia in some
groups of women.1 That this occurs only in certain individuals andola University of Technology,
Tel.: þ234 7039407465.
da).
iwanese Dermatological Associationot all users suggests that there might be some other underlying
cause.
Apart from environmental causes such as exposure to hair
relaxer or other chemical agents, congenital, infectious, autoim-
mune, or nutritional causes have also been identiﬁed to induce
alopecia. Agents such as cytotoxic drugs, irradiation treatment,
androgens, oral contraceptive pills, retinoids, angiotensin-
converting enzyme inhibitors, anticonvulsants, antidepressants,
and the anticoagulant heparin may cause drug-induced alopecia.2,3
Oral contraceptive-induced alopecia is especially common in
women using contraceptives containing androgenic progestin.
Moreover, hormonal replacement therapy consisting of high-dose
progesterone may also cause alopecia.4,5
Although deﬁciencies of various essential molecules and
elements have been associated with one form of alopecia or the
other (e.g. vitamin D), and decreased zinc level has been reported ton. Published by Elsevier Taiwan LLC. All rights reserved.
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with prolonged exposure to hair relaxer, the role of some other
elements and the onset (age) of exposure in hair relaxer-induced
alopecia has not been investigated. A study of this nature is
needed because hair abnormalities have been reported to have
a tremendous psychosocial effect onwomen, especially adolescents
and young adults, who thereby suffer a great deal of anxiety over
their physical appearance. Abnormalities may appear in a variety of
forms, e.g., an alteration in the appearance or quality of the hair,
weathered or fractured hair, or alopecia.
The aim of this study was to determine if there is any difference
in the presentation of serum levels of minerals and vitamins in
these two categories of alopecia subjects and to investigate, using
a correlation study, if a relationship exists between the duration of
exposure/alopecia and the level of essential trace elements.
Methodology
Subjects
The researchwas conducted in the city of Ibadan, Nigeria. The study
involved three groups of participants: two alopecia groups of 20
subjects each, and a third, control, group consisting of 30 subjects.
Eligible participants were recruited at hair treatment saloons at
different locations within the city. Subjects were recruited by
a simple random sampling technique after a period of sensitization.
Samples were collected from subjects over a period of 10 weeks.
The ﬁrst group, Group A, consisted of women who had
commenced their use of hair relaxer in the second decade of life
and presented with alopecia; this group had a mean duration of
hair relaxer application of 25.1 years. The second group, Group B,
was composed of womenwho also exhibited alopecia but who had
commenced their use of relaxer later, in the third or fourth decade
of life, with a mean duration of hair relaxer application of 12.2
years. The frequency of relaxer use for both subgroups of subjects
with alopeciawas approximately four times per year over the entire
period of usage. The control group, Group C, consisted of users of
relaxer who did not have alopecia; these subjects had a mean
relaxer usage of 26.5 years.
Subjects in Groups A and B had recession of the frontal hairline,
similar to the presentation of male pattern androgenic alopecia.
Womenwith female-pattern androgenic alopecia or any other type
of alopecia were excluded from this study. Women with a family
history of pathological alopecia, physiological or emotional stress,
and a history of medical conditions (e.g., psoriasis) that might affect
the outcome were also excluded. The purpose of the study was
described to the women, who gave their informed consent. They
provided information on their age, duration of exposure, duration
of alopecia, state of health, and drug history. Subjects with any of
the confounding factors capable of affecting serum micronutrientTable 1 Serum levels of indices of renal and hepatic function in two categories of alope
GROUP A Mean  SEM GROUP B Mean 
Urea (mmol/L) 3.52  0.32 3.83  0.39
Creatinine (mmol\L) 73.64  9.10 70.91  6.36
ALT (IU\L) 16.93  2.21 16.87  1.38
AST (IU\L) 18.93  1.35 18.73  1.38
ALP (IU\L) 56.27  4.68 55.80  4.84
GGT (IU\L) 14.67  1.73 14.73  1.43
Total bilirubin(mmol\L) 10.73  1.08 10.80  0.74
Total Protein (g\L) 69.1  1.2 69.0  1.3
Albumin (g\L) 38.3  0.9 35.4  0.6
Globulin (g\L) 31.8  1.6 33.7  1.4
ALP¼ alkaline phosphatase; ALT¼ alanine aminotransferase; AST¼ aspartate aminotran
*signiﬁcance at p < 0.05.levels (e.g. pregnancy, lactation, alcohol ingestion, vitamin and
mineral supplementation, malabsorption syndrome, malnutrition,
inﬂammatory bowel disease, etc.) were excluded from the study. All
study procedures conformed with the principle outlined in the
Declaration of Helsinki of 1975.
Biochemical determinations
A standard blood collection regimen was established for all groups.
Collection of blood took place between 10:00 AM and 12 noon.
Serum obtained after centifuging blood samples for 10 minutes at
3000 g was stored at e20 C until utilized for biochemical analyses.
The following biochemical analyses were carried out to determine
the levels of alanine and aspartate aminotransferases (AST and
ALT), g-glutamyl transferase (GGT), alkaline phosphatase (ALP),
urea, creatinine, total protein, albumin, globulin, and bilirubin.
Serum levels of copper, zinc, magnesium, manganese, vitamin A,
and vitamin E were also estimated. Levels of serum AST, ALT, ALP,
total bilirubin, and total protein were determined using the
methods of Bergmeyer et al (both AST and ALT),6 King and Arm-
strong,7 Malloy and Evelyn,8 and Lowry et al,9 respectively. The
trace element and vitamin levels were estimated using the atomic
absorption spectrometric and high-performance liquid chroma-
tography (HPLC) techniques respectively. A Buck Scientiﬁc 205
Atomic Absorption Spectrophotometer (Buck Scientiﬁc, East
Norwalk, Connecticut, USA) was used for the estimation of
elements, and a Hitachi 902 automated analyzer (supplied by
Roche Diagnostics, Germany) was used for the estimation of urea,
creatinine, bilirubin, total protein, albumin, and globulin. Serum
levels of vitamins were estimated using the HPLC Waters 626 LC
system.
Level of signiﬁcant difference between each of the alopecia
groups and the control group was determined using the Student t
test. Intergroup comparisonwas achieved using analysis of variance
(ANOVA). SPSS software (SPSS Inc., Chicago, IL, USA) was employed
for the statistical analysis. The degree of association between the
trace elements and other biochemical parameters and duration of
exposure was established using Pearson’s correlation coefﬁcient. In
each case, p < 0.05 was considered signiﬁcant.
Results
The results of indicators used to assess both renal and hepatic
function are presented in Table 1. Using ANOVA, there was no
signiﬁcant difference in the concentrations of urea and creatinine
(p > 0.05) in the two categories of alopecia subjects and the
controls. Moreover, hepatic enzymes ALT, AST, ALP, and GGT did not
differ signiﬁcantly in these three categories of subject (p > 0.05).
Although an intergroup comparison between Groups A, B, and C
showed that there was a signiﬁcant difference in albumin levelcia subjects and controls.
SEM GROUP C Mean  SEM F values P values
3.83  0.19 0.300 0.724
72.73  7.27 0.015 0.985
16.60  0.96 0.011 0.989
19.53  1.00 0.111 0.896
60.47  4.70 0.294 0.747
15.00  1.32 0.014 0.986
10.07  0.84 0.203 0.817
70.1  1.6 0.200 0.820
35.5  0.8 4.477 0.017*
34.1  1.6 0.614 0.546
sferase; GGT¼ g-glutamyl transferase; SEM¼ standard error of the mean.
Table 2 Age, duration of exposure and serum levels of selected minerals and vitamins in two categories of alopecia subjects and controls.
GROUP A Mean  SEM GROUP B Mean  SEM GROUP C Mean  SEM F values P values
Zn (mmol\L) 12.11  0.37 11.96  0.90 14.27  0.34 4.777 0.014*
Cu (mmol\L) 15.85  0.69 14.55  0.66 15.71  0.82 0.962 0.390
Mg (mmol\L) 0.79  0.05 0.70  0.06 0.70  0.05 1.091 0.345
Mn (nmol\L) 114.3  7.2 112.86  5.22 108.54  5.23 0.250 0.780
Vitamin A (mmol\L) 1.91  0.17 1.96  0.14 2.03  0.11 0.194 0.824
Vitamin E (mmol\L) 15.78  1.39 18.10  1.39 16.01  1.16 0.801 0.455
Age (years) 41.5  1.9 42.9  2.2 40.9 1.7 0.259 0.773
Duration of alopecia (years) 14.3  1.5 8.1  0.9
SEM¼ standard error of mean.
*signiﬁcance at p < 0.05.
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signiﬁcantly (p > 0.05). The results of the ANOVA comparison
(Table 2) showed that of all the minerals and vitamins estimated
(zinc, copper, magnesium, manganese, and vitamins A and E) only
the level of zinc was signiﬁcantly different (p < 0.05), the other
differences lacking signiﬁcance (p > 0.05).
The results of an intergroup comparison between Groups A and
B showed that their zinc levels were not signiﬁcantly different
(p > 0.05) using the Student t test, although both groups recorded
signiﬁcantly low zinc levels compared with Group C (control). On
the other hand, albumin was signiﬁcantly higher (p > 0.05) in
Group A compared with Group B. An intergroup comparison
(Student t test) showed that the duration of alopecia as well as the
duration of hair relaxer application was signiﬁcantly different
(p > 0.05) in both categories of alopecia subjects, with higher
mean  standard error of the mean values obtained for Group A
than Group B for the two variables; this was probably due to
differences in the age at which both groups had commenced hair
relaxer use.
A positive correlation was observed between the duration of
hair relaxer application and the duration of alopecia (r ¼ 0.608;
p ¼ 0.016); similarly, a positive correlation was noted between
duration of hair relaxer application and the period between the
commencement of application and the emergence of alopecia
(r ¼ 0.566; p ¼ 0.028) in Group B subjects. All these occurred in
association with a positive correlation (r ¼ 0.631; p ¼ 0.012)
between age and duration of alopecia. However, this study recor-
ded no correlation between alopecia and duration of hair relaxer
application.
Discussion
Hair loss can affect both sexes and all ages.10 Anything that
interrupts the normal hair cycle can trigger diffuse hair loss; such
triggers include physiological or emotional stress, nutritional
deﬁciencies, and endocrine imbalances.10 Hair loss, or alopecia, is
classiﬁed into two types: focal and diffuse. Common examples of
alopecia are alopecia areata, tinea capitis, androgenetic alopecia,
telogen efﬂuvium, alopecia totalis, alopecia universalis, etc.11
Chemically induced alopecia has also been described,12 and this
condition has been linked to a lowered level of zinc in the subjects.
Since not all zinc deﬁciency states cause alopecia, it is expected that
there might be some other confounding factors. For instance, both
alcohol ingestion and cigarette smoking cause zinc deﬁciency,
although these have not been clearly linked to alopecia, except in
Asian men, in whom smoking may be a factor associated with age-
related hair loss.13 Moreover, even though both zinc deﬁciency and
alopecia may coexist in a pregnant and postpartum women, this
type of alopecia may be more hormonally related, especially as an
alteration in the levels of other hormones, e.g., thyroxine and
prolactin, have been implicated in the pathogenesis of alopecia.14This study revealed that both serum zinc status and age at
commencement of relaxer use might have played an independent
or combined role as an etiologic factor in hair relaxer-induced
alopecia in Group B subjects, especially as a signiﬁcant decrease
in zinc level as well as a positive correlation (r ¼ 0.631; p ¼ 0.012)
between age and duration of alopecia was observed in these
subjects. Moreover, it took just about 5.29 years for alopecia to
commence after the initiation of hair relaxer use whereas, whereas
subjects in Group A had used hair relaxer for over a decade before
the commencement of their alopecia, an indication that early
exposure may confer some form of protection even in zinc-
deﬁcient individuals. This may be more so as the ages of subjects
in Groups A and Bwere not signiﬁcantly different (p> 0.05) and the
difference in duration of hair relaxer application between the two
groups was approximately 13 years, whereas the difference in time
to commencement of alopecia was just approximately 5.64 years.
This was further conﬁrmed by a positive correlation between
duration of hair relaxer application and duration of alopecia
(r ¼ 0.0608; p ¼ 0.016), as well as a positive correlation between
duration of hair relaxer application and the period between the
commencement of application and the emergence of alopecia
(r ¼ 0.631; p ¼ 0.012). Although signiﬁcantly different zinc levels
were not recorded between the two alopecia groups using an
intergroup comparison (Student t test), comparison using ANOVA
showed that both groups had signiﬁcantly decreased zinc levels
compared with controls (p < 0.05) This is in agreement with the
results of other studies that have linked alopecia to lowered zinc
level.15,16 Zinc in association with selenium helps in the proper
utilization of proteins and hormones in hair formation; moreover,
vitamins A, C, E and B6 in conjunction with these two minerals are
important in promoting hair regrowth.
Levels of trace elements such as copper, magnesium, and
manganese, on the other hand, were not signiﬁcantly increased in
the alopecia group compared with controls (p < 0.05). Although
Mussalo-Rauhamaa et al17 have raised the possibility of an altered
copper level in the establishment of alopecia areata, most studies
have consistently not shown a possible direct involvement of altered
serum magnesium and copper levels as etiological factors in the
pathogenesis of alopecia. Serum vitamin levels such as vitamin D
and biotin have been reported to be depleted in alopecia and daily
supplements of vitamin E may increase hair growth in people with
male pattern alopecia, but the results of this study recorded non
signiﬁcant difference for both serum vitamins A and E (p > 0.05) in
both alopecia groups compared with controls.
Hair follicles are unique in structure and are capable of excep-
tional regenerative potential. They are important for epidermal
homeostasis and re-epithelialization after damage to human skin.
Like other, more active and quickly proliferating organ systems, hair
follicles may be easily disturbed in their normal growth cycle by
systemic and local inﬂuences. Apart from infectious, autoimmune,
inﬂammatory, neoplastic, physical, and congenital causes, the use
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of diseases of hair follicles.18 As Borovicka et al1 have pointed out,
chemical insult to the hair follicle may result in lymphocytic inﬁl-
tration and perifollicular ﬁbrosis, thereby interfering with the
follicle’s potential for hair formation and leading to alopecia.
Moreover, this unique miniorgan has its own immune system and
hormonal milieu; zinc plays an important role in the immune
response, and an altered immune response is an important cause of
many types of alopecia. Therefore, it is also likely that the signiﬁ-
cant decrease in level of zinc in both groups of alopecia subjects
affected the immune system of their hair follicles. In addition, many
of the components of hair relaxer, e.g., thioglycolate, sodium
hydroxide, or calcium hydroxide, are known to disrupt disulﬁde
bonds in both skin cells and hair.
The signiﬁcant difference in the level of zinc in the alopecia
group compared with the control group might also have caused
a distortion in the role of zinc in gene expression as well as in
stabilizing the structure of proteins and nucleic acids that is
necessary for the proper functioning of all cells, including the hair
follicles. Speciﬁcally, Rice19 has highlighted that the gene SOX21
appears be responsible for hair loss in human subjects,19 although
a link has not been identiﬁed between zinc and this gene. Although
both hepatic and renal failure have been identiﬁed as a cause of
alopecia,20 the results of this study revealed a nonsigniﬁcant
difference (p> 0.05) in all the indices of renal and hepatic function.
Serum ALT, AST, ALP, GGT, bilirubin, total protein, albumin, urea,
and creatinine levels were not signiﬁcantly different in the alopecia
group comparedwith controls; this may be an indication that these
disorders did not play a role in the alopecia manifested by these
subjects.
Conclusion
Since altered serum zinc level alone was found to be a probable
cause of alopecia in the women in Groups A and B, it may not be
surprising to speculate that thesewomen probably had a lower zinc
level compared with the general population even before exposure
to hair relaxer. We are therefore suggesting that an assessment of
serum zinc level in the users of hair relaxer be carried out even
before initial exposure to it. One should perhaps encourage zinc
supplementation or an adjustment in nutritional content to include
foods rich in zinc that might delay or prevent the occurrence of
alopecia in many of the subjects who are constantly exposed to hair
relaxers for beauty treatment; care should, however, be exercised
not to exceed the recommended daily allowance as a higher than
recommended zinc intake level hinders the absorption of iron and
copper. Although copper may not play a direct role in hair forma-
tion, it helps in blood vessel formation, such that a decrease in itslevel may be detrimental to the scalp and may indirectly limit hair
growth. In addition, avoidance of chemical trauma to the scalp hair
as well as an encouragement of natural hairstyles may also be
helpful in this category of subjects.
This study is, however limited by the fact that only some of the
elements and vitamins already established as playing a role in the
pathogenesis of different types of alopecia were studied. Therefore,
further studies may be required to determine the levels of other
biomolecules, especially vitamin D and biotin, in these categories of
subject as the cause of hair relaxer-induced alopecia may be
multifaceted.
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